Richard Bassett
51 - 200 employees
Richard Bassett has worked on the following 18 EPO patent applications which have been published in the last five years:
MECHANICALLY COMPETENT SCAFFOLD FOR ROTATOR CUFF AND TENDON AUGMENTATION
- IPC classification:
- A61B 17/11, A61F 2/08
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ EXAMINATION IN PROGRESS
SELECTIVE CYSTEINE PROTEASE INHIBITORS AND USES THEREOF
- IPC classification:
- C07K 5/00, C07K 5/02, C07K 5/06, C07K 5/08, C07K 7/06
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ EXAMINATION IN PROGRESS
PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS RESISTANT ANIMALS
- IPC classification:
- A01K 67/027, C12N 15/00
- Applicant:
- The Curators Of The University Of Missouri
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ EXAMINATION IN PROGRESS
THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME
- IPC classification:
- A61K 38/38, A61K 38/55, A61K 47/48
- Applicant:
- Baxter International Inc
- Applicant:
- Baxter Healthcare SA
- Applicant:
- Baxalta Incorporated
- Applicant:
- Baxalta GmbH
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ GRANT OF PATENT INTENDED
MODIFIED ALGINATES FOR CELL ENCAPSULATION AND CELL THERAPY
- IPC classification:
- A61K 47/00, C08B 37/00, C40B 50/00
- Applicant:
- Massachusetts Institute of Technology (MIT) Inc.
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ GRANT OF PATENT INTENDED
BIOADHESIVE DRUG DELIVERY COMPOSITIONS
- IPC classification:
- A61K 9/48
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN
SYNTHESIS AND CHARACTERIZATION OF SECOND GENERATION BENZOFURANONE RING SUBSTITUTED NOSCAPINE ANALOGS
- IPC classification:
- A61K 31/4355, A61P 35/00, C07D 491/04
- Applicant:
- Georgia State University Research Foundation, Inc.
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN
CARBOCYANINES FOR G-QUADRUPLEX DNA STABILIZATION AND TELOMERASE INHIBITION
- IPC classification:
- C12Q 1/68
- Applicant:
- Georgia State University Research Foundation, Inc.
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ EXAMINATION IN PROGRESS
METHOD FOR CONVERTING AND PRODUCING CARBONATE MINERALS FROM CARBON DIOXIDE USING RECOMBINANT BIOCATALYST
- IPC classification:
- C12N 9/88, C12P 3/00
- Applicant:
- Postech Academy-Industry Foundation
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ EXAMINATION IN PROGRESS
BIOMATRICES TO ATTRACT AND RETAIN REGENERATIVE AND REPARATIVE CELLS
- IPC classification:
- A61K 38/18, A61K 47/42, A61L 24/10, A61P 9/10
- Applicant:
- Baxter International Inc
- Applicant:
- Baxter Healthcare SA
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN
CROSSLINKED CATION EXCHANGE POLYMERS, COMPOSITIONS AND USE IN TREATING HYPERKALEMIA
- IPC classification:
- A61K 31/74, A61P 1/00
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Agent:
- Eisenführ Speiser & Partner Patentanwälte Rechtsanwälte PartGmbB
- Status:
- █ EXAMINATION REQUESTED
Treatment of bladder dysfunction using liposomal botulinum toxin
- IPC classification:
- A61K 9/127, A61K 38/48, A61P 13/10
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN
IVIG modulation of chemokines for treatment of Multiple Sclerosis, Alzheimer's disease, and Parkinson's disease
- IPC classification:
- C12Q 1/68
- Applicant:
- Baxter International Inc
- Applicant:
- Baxter Healthcare SA
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ NO OPPOSITION FILED WITHIN TIMELIMIT
IVIG modulation of chemokines for treatment of Multiple Sclerosis, Alzheimer's disease, and Parkinson's disease
- IPC classification:
- C12Q 1/68
- Applicant:
- Baxter International Inc
- Applicant:
- Baxter Healthcare SA
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ NO OPPOSITION FILED WITHIN TIMELIMIT
IVIG modulation of chemokines for treatment of Multiple Sclerosis, Alzheimer's disease, and Parkinson's disease
- IPC classification:
- C12Q 1/68
- Applicant:
- Baxter International Inc
- Applicant:
- Baxter Healthcare SA
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ NO OPPOSITION FILED WITHIN TIMELIMIT
IVIG modulation of chemokines for treatment of Multiple Sclerosis, Alzheimer's disease, and Parkinson's disease
- IPC classification:
- C12Q 1/68
- Applicant:
- Baxter International Inc
- Applicant:
- Baxter Healthcare SA
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ NO OPPOSITION FILED WITHIN TIMELIMIT
INJECTABLE DENDRIMER HYDROGEL NANOPARTICLES
- IPC classification:
- A61K 47/48, A61P 25/28, A61P 31/00, C08G 73/02, C08L 79/02
- Applicant:
- Wayne State University
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Agent:
- Multiple attorneys, Withers & Rogers LLP
- Status:
- █ GRANT OF PATENT INTENDED
Compositions for prevention of adhesions and other barrier applications
- IPC classification:
- A61K 38/10, A61L 15/42, A61L 26/00
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ The patent has been granted